132 related articles for article (PubMed ID: 22114026)
1. The hexosamine biosynthetic pathway and O-GlcNAcylation drive the expression of β-catenin and cell proliferation.
Olivier-Van Stichelen S; Guinez C; Mir AM; Perez-Cervera Y; Liu C; Michalski JC; Lefebvre T
Am J Physiol Endocrinol Metab; 2012 Feb; 302(4):E417-24. PubMed ID: 22114026
[TBL] [Abstract][Full Text] [Related]
2. Elevated glucose levels impair the WNT/β-catenin pathway via the activation of the hexosamine biosynthesis pathway in endometrial cancer.
Zhou F; Huo J; Liu Y; Liu H; Liu G; Chen Y; Chen B
J Steroid Biochem Mol Biol; 2016 May; 159():19-25. PubMed ID: 26923859
[TBL] [Abstract][Full Text] [Related]
3. Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging.
Yeh CT; Rao YK; Ye M; Wu WS; Chang TC; Wang LS; Wu CH; Wu AT; Tzeng YM
Toxicol Appl Pharmacol; 2012 May; 261(1):31-41. PubMed ID: 22465936
[TBL] [Abstract][Full Text] [Related]
4. O-GlcNAcylation stabilizes β-catenin through direct competition with phosphorylation at threonine 41.
Olivier-Van Stichelen S; Dehennaut V; Buzy A; Zachayus JL; Guinez C; Mir AM; El Yazidi-Belkoura I; Copin MC; Boureme D; Loyaux D; Ferrara P; Lefebvre T
FASEB J; 2014 Aug; 28(8):3325-38. PubMed ID: 24744147
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase C ζ is a positive modulator of canonical Wnt signaling pathway in tumoral colon cell lines.
Luna-Ulloa LB; Hernández-Maqueda JG; Santoyo-Ramos P; Castañeda-Patlán MC; Robles-Flores M
Carcinogenesis; 2011 Nov; 32(11):1615-24. PubMed ID: 21859831
[TBL] [Abstract][Full Text] [Related]
6. A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth.
Lau T; Chan E; Callow M; Waaler J; Boggs J; Blake RA; Magnuson S; Sambrone A; Schutten M; Firestein R; Machon O; Korinek V; Choo E; Diaz D; Merchant M; Polakis P; Holsworth DD; Krauss S; Costa M
Cancer Res; 2013 May; 73(10):3132-44. PubMed ID: 23539443
[TBL] [Abstract][Full Text] [Related]
7. GFAT1/HBP/O-GlcNAcylation Axis Regulates
Jia C; Li H; Fu D; Lan Y
Biomed Res Int; 2020; 2020():1921609. PubMed ID: 32149084
[TBL] [Abstract][Full Text] [Related]
8. O-GlcNAcylation affects β-catenin and E-cadherin expression, cell motility and tumorigenicity of colorectal cancer.
Harosh-Davidovich SB; Khalaila I
Exp Cell Res; 2018 Mar; 364(1):42-49. PubMed ID: 29391154
[TBL] [Abstract][Full Text] [Related]
9. The influence of 5-aminosalicylic acid on the progression of colorectal adenomas via the β-catenin signaling pathway.
Munding J; Ziebarth W; Pox CP; Ladigan S; Reiser M; Hüppe D; Brand L; Schmiegel W; Tannapfel A; Reinacher-Schick AC
Carcinogenesis; 2012 Mar; 33(3):637-43. PubMed ID: 22198215
[TBL] [Abstract][Full Text] [Related]
10. Posttranslational, reversible O-glycosylation is stimulated by high glucose and mediates plasminogen activator inhibitor-1 gene expression and Sp1 transcriptional activity in glomerular mesangial cells.
Goldberg HJ; Whiteside CI; Hart GW; Fantus IG
Endocrinology; 2006 Jan; 147(1):222-31. PubMed ID: 16365142
[TBL] [Abstract][Full Text] [Related]
11. DIF-1 inhibits the Wnt/β-catenin signaling pathway by inhibiting TCF7L2 expression in colon cancer cell lines.
Jingushi K; Takahashi-Yanaga F; Yoshihara T; Shiraishi F; Watanabe Y; Hirata M; Morimoto S; Sasaguri T
Biochem Pharmacol; 2012 Jan; 83(1):47-56. PubMed ID: 22005519
[TBL] [Abstract][Full Text] [Related]
12. PGM3 regulates beta-catenin activity to promote colorectal cancer cell progression.
Zhang N; Liu S; Xu J; Ning T; Xie S; Min L; Zhu S; Zhang S; Zhu S
Exp Biol Med (Maywood); 2022 Sep; 247(17):1518-1528. PubMed ID: 35723049
[TBL] [Abstract][Full Text] [Related]
13. Differential sensitivity of colorectal cancer cell lines to artesunate is associated with expression of beta-catenin and E-cadherin.
Li LN; Zhang HD; Yuan SJ; Yang DX; Wang L; Sun ZX
Eur J Pharmacol; 2008 Jun; 588(1):1-8. PubMed ID: 18448095
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.
Schepeler T; Holm A; Halvey P; Nordentoft I; Lamy P; Riising EM; Christensen LL; Thorsen K; Liebler DC; Helin K; Ørntoft TF; Andersen CL
Oncogene; 2012 May; 31(22):2750-60. PubMed ID: 21963845
[TBL] [Abstract][Full Text] [Related]
15. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
16. O-GlcNAcylation Enhances Double-Strand Break Repair, Promotes Cancer Cell Proliferation, and Prevents Therapy-Induced Senescence in Irradiated Tumors.
Efimova EV; Appelbe OK; Ricco N; Lee SS; Liu Y; Wolfgeher DJ; Collins TN; Flor AC; Ramamurthy A; Warrington S; Bindokas VP; Kron SJ
Mol Cancer Res; 2019 Jun; 17(6):1338-1350. PubMed ID: 30885991
[TBL] [Abstract][Full Text] [Related]
17. Wnt9A Induction Linked to Suppression of Human Colorectal Cancer Cell Proliferation.
Ali I; Medegan B; Braun DP
Int J Mol Sci; 2016 Apr; 17(4):495. PubMed ID: 27049382
[TBL] [Abstract][Full Text] [Related]
18. O-GlcNAcylation is required for mutant KRAS-induced lung tumorigenesis.
Taparra K; Wang H; Malek R; Lafargue A; Barbhuiya MA; Wang X; Simons BW; Ballew M; Nugent K; Groves J; Williams RD; Shiraishi T; Verdone J; Yildirir G; Henry R; Zhang B; Wong J; Wang KK; Nelkin BD; Pienta KJ; Felsher D; Zachara NE; Tran PT
J Clin Invest; 2018 Nov; 128(11):4924-4937. PubMed ID: 30130254
[TBL] [Abstract][Full Text] [Related]
19. High levels of β-catenin signaling reduce osteogenic differentiation of stem cells in inflammatory microenvironments through inhibition of the noncanonical Wnt pathway.
Liu N; Shi S; Deng M; Tang L; Zhang G; Liu N; Ding B; Liu W; Liu Y; Shi H; Liu L; Jin Y
J Bone Miner Res; 2011 Sep; 26(9):2082-95. PubMed ID: 21638320
[TBL] [Abstract][Full Text] [Related]
20. Effective treatment of tumors with strong beta-catenin/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector.
Kuroda T; Rabkin SD; Martuza RL
Cancer Res; 2006 Oct; 66(20):10127-35. PubMed ID: 17047077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]